Rie Oka Selected Research

Bezafibrate

7/2011

Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: results from a crossover study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rie Oka Research Topics

Disease

9	Type 2 Diabetes Mellitus (MODY) 06/2021 - 01/2010
6	Glucose Intolerance 01/2018 - 05/2010
6	Insulin Resistance 01/2018 - 01/2012
3	Body Weight (Weight, Body) 06/2019 - 01/2015
2	Hypertension (High Blood Pressure) 08/2020 - 05/2010
2	Hypoglycemia (Reactive Hypoglycemia) 01/2019 - 01/2018
2	Diabetes Mellitus 01/2015 - 01/2014
2	Hyperglycemia 01/2015 - 01/2012
2	Hypertriglyceridemia 01/2014 - 05/2010
1	Cognitive Dysfunction 01/2020
1	Coma (Comas) 01/2019
1	Hyperthyroidism 11/2018
1	Obstructive Sleep Apnea 04/2018
1	Obesity 01/2015
1	Dyslipidemias (Dyslipidemia) 07/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2010
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2009
1	Anemia 01/2009
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2009

Drug/Important Bio-Agent (IBA)

15	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 05/2010
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 01/2018
3	HDL CholesterolIBA 01/2014 - 05/2010
2	AlbuminsIBA 06/2019 - 01/2009
2	LipidsIBA 06/2019 - 01/2015
2	Insulin (Novolin)FDA Link 01/2019 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 01/2015 - 07/2011
2	CholesterolIBA 07/2011 - 05/2010
1	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2020
1	glimepiride (Amarel)FDA LinkGeneric 01/2019
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2019
1	APTIBA 01/2019
1	SolutionsIBA 01/2019
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019
1	Sodium-Glucose Transport ProteinsIBA 04/2018
1	Fenofibrate (CiL)FDA LinkGeneric 07/2011
1	BezafibrateIBA 07/2011
1	Proprotein Convertase 9IBA 07/2011
1	AdipokinesIBA 07/2011
1	Alanine (L-Alanine)FDA Link 01/2010

Therapy/Procedure

3	Glycemic Control 06/2019 - 01/2015
2	Injections 01/2020 - 01/2019
1	Adrenalectomy 08/2020
1	Nephrectomy 08/2020
1	Nutrition Therapy (Medical Nutrition Therapy) 06/2019
1	Subcutaneous Injections 01/2019
1	Thyroidectomy 11/2018
1	Gastrectomy 01/2015
1	Bariatric Surgery 01/2015